Nutrition
Volume 23, Issue 3 , Pages 242-247 , March 2007

Folic acid therapy reduces plasma homocysteine levels and improves plasma antioxidant capacity in hemodialysis patients

  • Vinicius Daher Alvares Delfino, Ph.D.

      Affiliations

    • Nephrology Section, Department of Internal Medicine, State University of Londrina, Londrina, Brazil
    • Corresponding Author InformationCorresponding author. Tel./fax: +55-43-3323-9191.
    • ,
  • Areuza Célia de Andrade Vianna, Ph.D.

      Affiliations

    • Nephrology Section, Department of Internal Medicine, State University of Londrina, Londrina, Brazil
    • ,
  • Altair Jacob Mocelin, Ph.D.

      Affiliations

    • Nephrology Section, Department of Internal Medicine, State University of Londrina, Londrina, Brazil
    • ,
  • Décio Sabbatini Barbosa, Ph.D.

      Affiliations

    • Department of Applied Pathology, State University of Londrina, Londrina, Brazil
    • ,
  • Rosana Aiko Mise, M.Sc.

      Affiliations

    • Department of Applied Pathology, State University of Londrina, Londrina, Brazil
    • ,
  • Tiemi Matsuo, Ph.D.

      Affiliations

    • Department of Applied Mathematics, State University of Londrina, Londrina, Brazil

Received 24 May 2006 ,Revised 4 January 2007

References 

  1. Shik J, Parfrey PS. The clinical epidemiology of cardiovascular disease in chronic kidney disease. Curr Opin Nephrol Hypertens. 2005;14:550–557
  2. Friedman AL, Bostom AG, Selhub J, Levey AS, Rosemberg IH. The kidney and homocysteine metabolism. J Am Soc Nephrol. 2001;12:2181–2189
  3. Hoffer LJ. Testing the homocysteine hypothesis in end-stage renal disease: problems and possible solutions. Kidney Int. 2006;69:1507–1510
  4. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17:537–545
  5. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022
  6. Buccianti G, Baragetti I, Barmonti F, Furiani S, Dorighet V, Patrosso C. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol. 2004;17:405–410
  7. Medina MA, Urdiales JL, Amores-Sanches MI. Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem. 2001;268:3871–3882
  8. Massy ZA, Ceballos I, Chadefaux-Vekemens B, Nguyen-Khoa T, Deschamp-Latscha B, Drüke TB, et al. Homocysteine, oxidative stress, and endothelium function in uremic patients. Kidney Int. 2001;59(suppl 78):243–245
  9. Zheng H, Huang X, Zhang Q, Katz SD. Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. Kidney Int. 2006;69:679–684
  10. Huang RF, Hsu YC, Lin HL, Yang FL. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr. 2001;131:33–38
  11. Zhang R, Ma J, Xia M, Zhu H, Ling W. Mild hyperhomocysteinemia induced by feeding rats diets rich in methionine or deficient in folate promotes early atherosclerotic inflammatory processes. J Nutr. 2004;134:825–830
  12. Díez N, Pérez R, Hurtado V, Santidrián S. Hyperhomocysteinemia induced by dietary folate restriction causes kidney oxidative stress in rats. Br J Nutr. 2005;94:204–210
  13. Racek J, Rusnáková H, Trefil L, Siala KK. The influence of folate and antioxidants on homocysteine levels and oxidative stress in patients with hyperlipidemia and hyperhomocysteinemia. Physiol Rev. 2005;54:87–95
  14. Bayés B, Pastor MC, Bonal J, Junca J, Romero R. Homocysteine and lipid peroxidation in hemodialysis: role of folinic acid and vitamin E. Nephrol Dial Transplant. 2001;16:2172–2175
  15. Chiarello PG, Vannucchi MTI, Neto MM, Vannuchi H. Hyperhomocysteinemia and oxidative stress in hemodialysis: effects of supplementation with folic acid. Int J Vitam Nutr Res. 2003;73:431–438
  16. Gonin JM. Folic acid supplementation to prevent adverse events in individuals with chronic kidney disease and end stage renal disease. Curr Opin Nephrol Hypertens. 2005;14:277–281
  17. Daugirdas JT. Second generation logarithmic estimates of single pool volumes Kt/V: an analysis of error. J Am Soc Nephrol. 1993;4:1205–1213
  18. Torres RL, Torres LS, Gamaro GD, Fontella FU, Silveira PP, Moreira JSR, et al. Lipid peroxidation and total radical-trapping potential of the lungs of rats submitted to chronic and sub-chronic stress. Braz J Med Biol Res. 2004;37:185–192
  19. Jackson P, Loughrey CM, Lightbody JH, NcNamee PT, Young IS. Effects of total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem. 1995;41:1135–1138
  20. Erdogan C, Unlüçerçi Y, Türkmen A, Kuru A, Cetin O, Bekpinar S. The evaluation of oxidative stress in patients with chronic renal failure. Clin Chim Acta. 2002;322:157–161
  21. Mircescu G, Capusa C, Stoian I, Vargolici B, Barbulescu C, Ursea N. Global assessment of serum antioxidant status in hemodialysis patients. J Nephrol. 2005;18:599–605
  22. Annuk M, Soveri I, Zilmer M, Lind L, Hulthe J, Fellström B. Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol. 2005;18:721–726
  23. Lucchi L, Iannone A, Bergamini S, Stipo L, Perrone S, Ugeri S, et al. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis. Artif Organs. 2005;29:832–837
  24. Barbosa DS, Cecchini R, El Kadri MZ, Rodríguez MAM, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil ω-3 fatty acids. Nutrition. 2003;19:837–842
  25. Ducloux D, Klein A, Devillard N, Chalopin JM. Impact of malnutrition-inflammation on the association between homocysteine and mortality. Kidney Int. 2006;69:331–335
  26. Zoccali C, Mallamaci F. Homocysteine and the risk of end-stage renal disease: a matter of context. Kidney Int. 2006;69:204–206
  27. Locatelli F, Fouque D, Heimburger O, Drüke TB, Cannata-Andía JB, Hörl WH, et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant. 2002;17:563–572
  28. Wang AYM, Sea MMM, Ip R, Law MC, Chow KM, Lui SF, et al. Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr. 2002;76:569–576
  29. Fissell RB, Bragg-Gresham JL, Gillespie BW, Goodkin DA, Bommer J, Saito A, et al. International variation in vitamin prescription and association with mortality in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44:293–299
  30. Touam M, Zingraff J, Jungers P, Chadefaux-Vekemans B, Drüeke T, Massy ZA. Effective correction of hyperhomocysteinemia in hemodialysis patients by intravenous folinic acid and pyridoxine therapy. Kidney Int. 1999;56:2292–2296
  31. Caruso R, Campolo J, Sedda V, De Chiara B, Dellanoce C, Baudo F. Effect of homocysteine lowering by 5-methyltetrahydrofolate on redox status in hyperhomocysteinemia. J Cardiovasc Pharmacol. 2006;47:549–555
  32. Roncalés M, Achón M, Manzarbeitia F, Maestro de las Casas C, Ramírez C, Varela-Moreiras G, et al. Folic acid supplementation for 4 weeks affects liver morphology in aged rats. J Nutr. 2004;134:1130–1133
  33. Assanelli A, Bonanome A, Pezzini A, Albertini F, Maccalli P, Grassi M, et al. Folic acid and vitamin E supplementation effects on homocysteinemia, endothelial function and plasma antioxidant capacity in young myocardial-infarction patients. Pharmacol Res. 2004;49:79–84
  34. Abdelfatah A, Ducloux D, Gérard T, Gérard M, Alber D, Chalopin JM. Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients. Transplantation. 2002;73:663–665
  35. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med. 2001;30:1390–1399
  36. Wanner C, Krane V, März W, Olschewski M, Mann JFE, Ruf G, et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005;353:238–248

PII: S0899-9007(07)00009-3

doi: 10.1016/j.nut.2007.01.002

Nutrition
Volume 23, Issue 3 , Pages 242-247 , March 2007

Article Tools